聚己内酯在药物载体方面的研究进展  

Research Progresses of Poly-ε-caprolactone as Drug Carriers

作　　者：葛祥军 田源 熊向源[1] 龚妍春[1] 李资玲[1] 李玉萍[1] 

机构地区：[1]江西科技师范大学生命科学学院,南昌330013 [2]中国医药工业有限公司,北京100190

出　　处：《高分子通报》2017年第3期11-18,共8页Polymer Bulletin

基　　金：国家自然科学基金项目(21264009);江西省主要学科学术和技术带头人培养计划(20153BCB22009);江西省高等学校科技落地计划项目(KJLD13071);校级研究生创新专项资金项目(YC2015-X09)

摘　　要：聚己内酯(poly-ε-caprolactone,PCL)是一种人工合成的聚酯类高分子材料,对人体无毒,具有良好的生物相容性、生物可降解性和无免疫原性。PCL还对其它聚合物具有良好的相容性,可以制备出多种性能优良的共聚物或共混物,因此PCL及其共聚物、共混物作为药物载体的研究受到国内外研究者的高度重视。此外,PCL因其在人体中的降解过程十分缓慢可作为药物控释材料,目前已经获得美国FDA的批准。本文将从聚己内酯的合成与改性及其各剂型在药物载体方面的研究进展进行综述。Poly-e-caprolactone（PCL） is a synthetic polyester with excellent biocompatibility,biodegradability,nonimmunogenicity and non-toxic to human body.Due to its good compatibility with other polymers,it can be prepared into a variety of copolymers or blends with excellent properties.Therefore,research about PCL and its copolymers and blends as drug carriers have stolen the spotlight of synthetic macromolecular drug delivery systems.In addition,due to its long-term degradation in vivo,PCL used as materials for controlled release of drugs has already received US FDA＆#39;s approval.In this article,progresses in PCL synthesis and modification and its formulations of drug delivery system are reviewed.

关 键 词：聚己内酯 共聚物 水溶胶 纳米粒子 胶束 囊泡 

分 类 号：TQ317[化学工程—高聚物工业] TQ460.4